Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;22(1):53-8.
doi: 10.1089/mdr.2014.0307. Epub 2015 Jul 31.

Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole

Rodrigo E Mendes  1 , Lalitagauri M Deshpande  1 , Andrew J Costello  1 , David J Farrell  1 , Ronald N Jones  1 , Robert K Flamm  1
Affiliations

Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole

Rodrigo E Mendes et al. Microb Drug Resist. 2016 Jan.

Abstract

Baseline methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients with nosocomial and community-acquired pneumonia collected during Phase 3 trials for ceftobiprole were characterized. Eighty-four unique isolates from patients enrolled in Europe (50.0%), Asia-Western Pacific region (APAC; 20.2%), North America (19.0%), Latin America (8.3%), and South Africa (2.4%) were included. Antimicrobial susceptibility testing was performed by broth microdilution and isolates screened for Panton-Valentine leukocidin. SCCmec and agr types were determined. Strains were subjected to pulsed-field gel electrophoresis and spa typing. Clonal complexes (CCs) were assigned based on spa and/or multilocus sequence typing. Most isolates were CC5-MRSA-I/II/IV (44.0%; 37/84), followed by CC8-MRSA-IV (22.6%; 19/84) and CC239-MRSA-III (21.4%; 18/84). Other MRSA formed seven clonal clusters. Isolates from North America were associated with USA100, while those from South America belonged to the Cordobes/Chilean CC. A greater clonal diversity was observed in Europe; however, each country had CC5, CC8, or CC239 as prevalent lineages. Isolates from APAC were CC5-MRSA-II (47.1%; 8/17) or CC239-MRSA-III (47.1%; 8/17). Isolates carrying SCCmec I and III had ceftobiprole MIC50 values of 2 μg/ml, while those isolates with SCCmec II and IV had MIC50 values of 1 μg/ml. Ceftobiprole inhibited 96% and 100.0% of the isolates at ≤ 2 and ≤ 4 μg/ml, respectively. These isolates represented common circulating MRSA clones. Ceftobiprole demonstrated in vitro activity with a slight variation of minimum inhibitory concentrations (MICs) according to SCCmec or clonal type.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Albrecht N., Jatzwauk L., Slickers P., Ehricht R., and Monecke S. 2011. Clonal replacement of epidemic methicillin-resistant Staphylococcus aureus strains in a German university hospital over a period of eleven years. PLoS One 6:e28189. - PMC - PubMed
    1. Amorim M.L., Aires de Sousa M., Sanches I.S., Sa-Leao R., Cabeda J.M., Amorim J.M., and de Lencastre H. 2002. Clonal and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) from a Portuguese hospital over time. Microb. Drug Resist. 8:301–309 - PubMed
    1. Awad S.S., Rodriguez A.H., Chuang Y.C., Marjanek Z., Pareigis A.J., Reis G., Scheeren T.W., Sanchez A.S., Zhou X., Saulay M., and Engelhardt M. 2014. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia. Clin. Infect. Dis. 59:51–61 - PMC - PubMed
    1. Blanc D.S., Petignat C., Wenger A., Kuhn G., Vallet Y., Fracheboud D., Trachsel S., Reymond M., Troillet N., Siegrist H.H., Oeuvray S., Bes M., Etienne J., Bille J., Francioli P., and Zanetti G. 2007. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. J. Clin. Microbiol. 45:3729–3736 - PMC - PubMed
    1. Bogdanovich T., Clark C., Ednie L., Lin G., Smith K., Shapiro S., and Appelbaum P.C. 2006. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. Antimicrob. Agents Chemother. 50:2050–2057 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources